The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of perioperative treatment (tx) among patients (pts) undergoing radical resection (RR) for muscle-invasive urothelial cancer (MIUC) in France, Germany, Italy, Spain, the United Kingdom, the United States, Canada, China, and Japan.
 
Edward I Broughton
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jürgen E. Gschwend
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
 
J. Alfred Witjes
Honoraria - Astellas Pharma; AstraZeneca; Beigene; Bristol-Myers Squibb/Pfizer; Ferring; Janssen; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD; Nucleix; Oncodiag; Sanofi/Aventis
 
Mia Berry
Research Funding - Health Economics and Outcomes Research (HEOR) (Inst)
 
Michael Kostikas
Research Funding - Health Economics and Outcomes Research (HEOR) (Inst)
 
Rachel Montgomery
Employment - AstraZeneca (I)
Stock and Other Ownership Interests - AstraZeneca (I)
Research Funding - Health Economics and Outcomes Research (HEOR) (Inst)
 
Annabel Lambert
Research Funding - Health Economics and Outcomes Research (HEOR) (Inst)
 
Siguroli Teitsson
Employment - Health Economics and Outcomes Research (HEOR)
Consulting or Advisory Role - PAREXEL
 
Neil Milloy
Research Funding - Health Economics and Outcomes Research (HEOR) (Inst)